Feb 14 (Reuters)-
Medrx.Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2024 Dec 31, 2023 Dec 31, 2025 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 257 mln 29 mln 122 mln
(+773.3 pct) (-50.3 pct) (-52.5 pct)
Operating loss 793 mln loss 933 mln loss 1.34
Recurring loss 755 mln loss 930 mln loss 1.34
Net
Net loss 806 mln loss 932 mln loss 1.35
EPS loss 18.56 yen loss 26.82 yen loss 28.43 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Medrx.Co., Ltd..
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T